Pharmaceutical PV DIV - FSB
Ended Awarded Last action
- Contract number
- SPE2DU26FEMQH
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $58,787
Award facts
- Contract value 100% obligated
- $58,786.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $58,786.60 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois. This delivery order, issued on January 6, 2026 with an ultimate completion date of January 27, 2026, was not issued under any set-aside designation, reflecting the contractor's competitive capability in unrestricted federal procurement. DMS Pharmaceutical Group will supply pharmaceutical products and medical consumables to support Department of Defense healthcare operations, with performance based in Park Ridge, Illinois.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion government-wide acquisition strategy. DMS Pharmaceutical Group's master contract, valued at $499,999,999 through December 31, 2036, authorizes the company to supply a comprehensive range of pharmaceutical products including branded and generic prescription medications, biologics, vaccines, specialty pharmaceuticals, and medical consumables to military healthcare facilities worldwide. The contractor has demonstrated substantial federal contracting activity with the Defense Logistics Agency, supplying critical medications spanning oncology treatments, immunosuppressants, emergency medications, and routine pharmaceuticals to support the military medical supply chain.
Quick answers
Who was awarded contract SPE2DU26FEMQH?
SPE2DU26FEMQH was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 6, 2026.
How much is contract SPE2DU26FEMQH worth?
The government has obligated $58,787 on SPE2DU26FEMQH.
Is contract SPE2DU26FEMQH an order under another contract?
Yes. SPE2DU26FEMQH is a delivery order under SPE2DU25D9517, an indefinite delivery contract.
Was contract SPE2DU26FEMQH competed?
The extent of competition for SPE2DU26FEMQH was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award